IBRX Financing Cash Flow
Immunitybio Inc · Financing Cash Flow
IBRX Financing Cash Flow
Latest reported$496.78Mperiod ending
IBRX TTM Cash from Financing ($64.41M → $496.78M)
TTM financing cash flow
High-resolution chart · PNG
IBRX financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 496,782,000 | |
| 625,149,000 | |
| 400,241,000 | |
| 452,276,000 | |
| 294,339,000 | |
| 270,423,000 | |
| 281,630,000 | |
| 375,240,000 | |
| 597,160,000 | |
| 491,678,000 | |
| 558,341,000 | |
| 467,742,000 | |
| 354,226,000 | |
| 310,799,000 | |
| 233,613,000 | |
| 449,626,000 | |
| 368,296,000 | |
| 466,648,000 | |
| 505,443,000 | |
| 179,731,000 | |
| 200,292,000 | |
| 189,295,000 | |
| 150,675,000 | |
| 150,373,000 | |
| 87,116,000 | |
| -725,000 | |
| 38,593,000 | |
| 38,284,000 | |
| 38,209,000 | |
| 38,509,000 | |
| -771,000 | |
| -3,543,000 | |
| -18,375,000 | |
| -34,600,000 | |
| -34,983,000 | |
| -35,945,000 | |
| -23,989,000 | |
| -14,138,000 | |
| -15,560,000 | |
| -11,150,000 | |
| 234,920,000 | |
| 315,465,000 | |
| 317,333,000 | |
| 375,556,000 | |
| 132,604,000 | |
| 64,550,000 | |
| 64,407,000 |